Product Recalls in Rhode Island

Product recalls affecting Rhode Island — including food, drugs, consumer products, medical devices, and vehicles distributed to Rhode Island. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,560 recalls have been distributed to Rhode Island in the last 12 months.

47,970 total recalls
2,560 in last 12 months

Showing 20612080 of 13,384 recalls

DrugMarch 22, 2023· Direct Rx

Recalled Item: Alprazolam C-IV Recalled by Direct Rx Due to CGMP Deviations: Repackaging...

The Issue: CGMP Deviations: Repackaging firm recalling due to potential product cross...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 22, 2023· Direct Rx

Recalled Item: Alprazolam C-IV Recalled by Direct Rx Due to CGMP Deviations: Repackaging...

The Issue: CGMP Deviations: Repackaging firm recalling due to potential product cross...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Simvastatin 10 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Ropinirole 2mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Simvastatin 40 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Atorvastatin 10 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Glimepiride 2 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Tadalafil 5 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Atorvastatin 20 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 40mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 5mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Doxazosin 2 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 5mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Aripiprazole 5mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 10mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Ropinirole 0.5 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: recalling drug products following an FDA inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: recalling drug products following an FDA inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: recalling drug products following an FDA inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 17, 2023· Ascend Laboratories, LLC

Recalled Item: Aripiprazole Tablets Recalled by Ascend Laboratories, LLC Due to Out of...

The Issue: Out of specification (OOS) for Spectroscopic Identification test by IR.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund